Rodríguez-González M, Espinosa-Rosales F

Language: Spanish
References: 12
Page: 63-71
PDF size: 1064.28 Kb.

Text Extraction

No abstract.

REFERENCES

1. Tanno LK. Dissemination of definitions and concepts of allergic and hypersensitivity conditions. World Allergy Organization Journal. 2016;9:24.

2. Mallol J. The International Study of Asthma and Allergies in CHildhood (ISAAC) Phase Three: A global synthesis. Allergol Immunopahol. 2013;41(2):73-85.

3. Barnes PJ. Molecular mechanisms of corticosteroids in allergic diseases. Allergy. 2001;56:928-936.

4. Bacharier LB. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 2008:63:5-34.

5. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2016.

6. Weiler JM et al. Exercise-induced bronchoconstriction update—2016. J Allergy ClinImmunol 2016. In Press Corrected Proof.

7. ARIA (Allergic Rhinitis and its Impact on Asthma) 2008 Update.

8. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol. 2012;22:1-12.

9. Akdis CA. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118:152-69.

10. Brazzini B, Pimpinelli N. New and established topical corticoste- roids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol. 2002;3:47-58.

11. Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009;79(2):135-140.

12. European Academy of Allergology and Clinical Immunology/ American Academy of Allergy. EAACI GUIDELINESFoodAllergy and Anaphylaxis. 2014